![\"\"](\"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2020\/10\/4000-1-24-1.jpg\")
<\/p>\n<\/p>\n
Cancer Genetics, Inc. <\/strong>concerning potential violations of the federal securities laws and\/or breaches of fiduciary duties relating to its merger with StemoniX, Inc. Under the merger agreement, Cancer Genetics will acquire all of the outstanding capital stock of StemoniX in exchange for a number of shares of its common stock, with current equity holders of Cancer Genetics expected to own 22% of the common stock of the combined company.<\/p>\n Yintech Investment Holdings Limited <\/strong>concerning potential violations of the federal securities laws and\/or breaches of fiduciary duties relating to its sale to a group of rollover shareholders that includes members of Yintech’s management and board of directors. Under the terms of the merger agreement, holders of Yintech ordinary shares will receive $0.365<\/span> in cash per share, and holders of Yintech American depository shares (“ADS”) will receive $7.30<\/span> in cash per ADS. <\/p>\n Otelco Inc. <\/strong>concerning potential violations of the federal securities laws and\/or breaches of fiduciary duties relating to its sale to affiliates formed by Oak Hill Capital for $11.75<\/span> per share. <\/p>\n BMC Stock Holdings, Inc. <\/strong> <\/strong>concerning potential violations of the federal securities laws and\/or breaches of fiduciary duties relating to its sale to Builders FirstSource, Inc. Under the terms of the agreement, BMC shareholders will receive 1.3125 shares of Builders FirstSource common stock for each share of BMC common stock. <\/p>\n Halper Sadeh LLP may seek increased consideration, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders.<\/p>\n Shareholders are encouraged to contact the firm free of charge<\/strong> to discuss their legal rights and options. Please call Daniel Sadeh<\/span> or Zachary Halper<\/span> at (212) 763-0060 or email sadeh@halpersadeh.com or zhalper@halpersadeh.com.<\/p>\n Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.<\/p>\n Attorney Advertising. Prior results do not guarantee a similar outcome.<\/p>\n Contact Information: Tags:<\/b> Halper Sadeh LLP
Halper Sadeh LLP
Daniel Sadeh, Esq.<\/span>
Zachary Halper, Esq.<\/span>
(212) 763-0060
sadeh@halpersadeh.com
zhalper@halpersadeh.com
https:\/\/www.halpersadeh.com<\/p>\nSee Campaign: <\/strong>https:\/\/www.halpersadeh.com<\/a>
Contact Information:<\/b>
Halper Sadeh LLP
\nDaniel Sadeh, Esq.
\nZachary Halper, Esq.
\n(212) 763-0060
\nsadeh@halpersadeh.com
\nzhalper@halpersadeh.com
\nhttps:\/\/www.halpersadeh.com<\/p>\n
<\/a>, Wire<\/a>, Legal Newswire<\/a>, United States<\/a>, English<\/a><\/p>\n<\/div>\n
\nContact Information:<\/h3>\n
\nDaniel Sadeh, Esq.
\nZachary Halper, Esq.
\n(212) 763-0060
\nsadeh@halpersadeh.com
\nzhalper@halpersadeh.com\u00a0\u00a0
\nhttps:\/\/www.halpersadeh.com<\/p>\n<\/p><\/div>\n","protected":false},"excerpt":{"rendered":"Cancer Genetics, Inc. concerning potential violations of the federal securities laws and\/or breaches of fiduciary duties relating to its merger with StemoniX, Inc. Under the merger agreement, Cancer Genetics will acquire all of the outstanding capital stock of StemoniX in exchange for a number of shares of its common stock, with current equity holders of Cancer … Continue reading IMPORTANT SHAREHOLDER ALERT: Halper Sadeh LLP Reminds Shareholders About Its Ongoing Investigations; Investors are Encouraged to Contact the Firm – CGIX, YIN, OTEL, BMCH<\/span><\/a> Continue Reading